Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join

The Rabbit Hole

| 1 Comment
September 10, 2012.

German pharmaceutical conglomerate Habsucht-Kilne laboratories announced today that phase 3 clinical trials of their new HIV drug, Pleonexia, are now underway. Pleonexia - a four drug combination also known as Cynivex - is said to have eliminated all traces of HIV from a cohort of thirty test subjects.


Speaking from outside his summer home (pictured above), Habsucht-Kilne spokesperson Hans Axelsson advised that the annual anticipated (wholesale) cost per subject of Pleonexia will be approximately €4.2 million (Euros). When questioned why the drug will be priced so high, Axelsson explained that "our development costs have been exceptionally high for this product".

On a related note, U.S. company Engenew has completed phase 2 trials of their CCR5 gene modifier, Lexigen (Interlexin-6), which has thus far proven to completely block HIV from infecting host leucocytes.There is no word yet of the expected cost of Lexigen, but Engenew representatives are said to be "hopeful" that the gene-therapy cure will be less than the cost of Plexonia.

   Okay, so none of this is real, of course, but you do have to wonder why our meds cost so much and where the money really goes.


To be fair, the drug companies do incur large R&D and other costs, but the numbers do make you wonder how much they really spend and how much profit they make inventing, manufacturing and selling the pills that keep us well. It certainly makes me wonder.

(D.H. Weiss is now writing his second novel, yet to be named. To read chapter one of his first work of fiction, "From Seven Till Dawn", visit )

Sean on:

1 Comment

Show Comment(s)

Comments on David Weiss's blog entry "The Rabbit Hole"

yiek is all I can say
BUT what do they mean by " eliminated all traces of HIV from a cohort of thirty test subjects."
Do they mean they went UD and sayed that way as long as they took the drugs
Or they removed the reservoir (big news)

If they did then it is worth the price tag (not morally but...)
if not then why would anyone pay so much cas for a drug that just does what other drugs do

Leave a comment



My Favorite Links

Subscribe to Blog

About this Entry

This page contains a single entry by David Weiss published on September 6, 2012 11:21 PM.

It's Conditional was the previous entry in this blog.

FOR SALE: One soul, slightly used. is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.



The opinions expressed by the bloggers and by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong and/or its employees.

Smart + Strong is not responsible for the accuracy of any of the information contained in the blogs or within any comments posted to the blogs.

© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy